PDA

View Full Version : Metastatic breast cancer: AstraZeneca's Faslodex (fulvestrant) approved for new indic

News
03-07-2016, 08:33 AM
AstraZeneca has announced that the US Food and Drug Administration (FDA) has approved a new indication in the US, expanding the use of Faslodex® (fulvestrant) to include use in combination with...

More... (http://www.medicalnewstoday.com/releases/307523.php)